Status:
COMPLETED
New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Muscular Diseases
Spinal Muscular Atrophy
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study aims to refine the capability of MSOT to characterise muscle tissue and to determine non-invasive, quantitative biomarkers for the disease assessment in patients with spinal muscular atroph...
Detailed Description
SMA is an autosomal-recessive disorder, characterized by progressive muscle weakness and atrophy with an incidence of 1/10,000. The condition is caused by a homozygous deletion or mutation in the surv...
Eligibility Criteria
Inclusion
- genetically proven SMA
Exclusion
- Pregnancy
- Tattoo on skin to be examined
- For healthy volunteers only: suspected muscular disease/myopathia
Key Trial Info
Start Date :
November 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04115475
Start Date
November 7 2019
End Date
January 30 2020
Last Update
November 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics and Adolescent Medicine
Erlangen, Bavaria, Germany, 91054